Low grade lymphomas are non-Hodgkin lymphoma (NHL) that grow slowly and are often asymptomatic compared with other types of NHL. However, they may still require ongoing monitoring and treatment. There ...

Classifying non-Hodgkin lymphoma (NHL) can be confusing because there are so many types. The World Health Organization system is often used. It groups NHL by the appearance of the lymphoma cells, the ...

Hodgkin lymphoma (formerly known as Hodgkin disease), which involves an abnormal type of lymphocyte called Reed-Sternberg cells Non-Hodgkin lymphoma, which does not contain Reed-Sternberg cells Both ...

Researchers at the University of Southampton have identified a new subtype of lymphoma which could pave the way to improved ...

Researchers at the University of Southampton have identified a new subtype of lymphoma that could pave the way to improved and more targeted treatments for some blood cancer patients. The cancer ...

B-cell lymphoma is a type of non-Hodgkin’s lymphoma. This cancer affects immune system cells. Depending on the type, B-cell lymphoma can be slow- or fast-growing and affect different body parts.

Researchers have identified a new subtype of lymphoma which could pave the way to improved and more targeted treatments for ...

The immune system produces immune cells that travel through the lymphatic system to fight off infections and diseases. T-cell lymphoma is a type of blood cancer that affects specific immune cells ...

Q: Could you tell me about the causes, treatment and remission rates for Burkitt lymphoma? A: Burkitt lymphoma is a highly aggressive, rapidly growing type of B cell lymphoma. It’s caused by an ...

—The subtype of lymphoma and the timing of anticancer treatment was shown to directly affect the level of seroconversion in cancer patients administered COVID vaccination. Reviewed by Catherine E. Lai ...

It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...